Press Room

Share

Proposed Funding Level for National Institutes of Health A Victory for Cancer Research

November 1, 2007

WASHINGTON, D.C. -- November 1, 2007 -- "The decision of Congressional negotiators to pursue funding for the National Institutes of Health (NIH) that exceeds both the House- and Senate-passed funding levels is a major step forward in support of ground-breaking and lifesaving cancer research.

"We applaud Chairmen David Obey and Tom Harkin and ranking members Arlen Specter and James Walsh for their efforts. These funds, included in the Labor, Health and Human Services, and Education conference report, are a critical part of ensuring that promising new discoveries make it out of the laboratory and into doctors’ offices.

"While the President has vowed to veto the spending bill based on its overall size, we urge Congress to continue to sustain the critical progress that has been made in cancer research and to reject the President’s call to cut medical research funds.

"After years of cut and flat funding, this proposed increase would help ensure that the progress in the fight against cancer will not be stalled. Cancer patients and survivors in every district across this country are depending on their lawmakers to continue to make this a top priority."

ACS CAN is the nonprofit, nonpartisan sister advocacy organization of the American Cancer Society, dedicated to eliminating cancer as a major health problem. ACS CAN works to encourage lawmakers, candidates and government officials to support laws and policies that will make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer. For more information, click here.

More Press Releases AboutCancer Research Funding

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more